Immunohistochemical Staining Protocol for ILT4 Expression and Microvessel Density Analysis
In line with a previous protocol, 18 (link) IHC staining was performed using immunohistochemical staining kit (zsbio; Cat No. SP‐9000). The primary and secondary antibodies are listed in Table S1. The sections were analyzed simultaneously by two independent investigators. Cell staining was evaluated following the immunoreactive score (IRS) proposed by Remmele and Stegner with slight modifications. 20 (link) For statistical analyses, cases with an IRS of 0–3 were defined as negative; otherwise, they were defined as positive. The cutoff scores for low and high ILT4 expression were <4 and ≥4, respectively. Microvessel density (MVD) was calculated according to a modification of Weidner's method. 21
Partial Protocol Preview
This section provides a glimpse into the protocol. The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Wang S., Wang J., Gong W., Zhang F., Chen X., Xu H., Han Y., Fu X., Wang L., Li J., Gao A, & Sun Y. (2024). ILT4 facilitates angiogenesis in non‐small cell lung cancer. Cancer Science, 115(5), 1459-1475.
Other organizations :
Jinan Central Hospital, Yuhuangding Hospital, Qingdao University, University of Science and Technology of China, Qilu Hospital of Shandong University, Shandong University
Cell staining as evaluated by immunoreactive score (IRS)
Microvessel density (MVD)
control variables
Immunohistochemical staining protocol used (zsbio immunohistochemical staining kit, SP-9000)
controls
Positive control: None mentioned
Negative control: None mentioned
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required